FREDERICK, Md., Nov. 26, 2014
/PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the
maker of advanced consumer and healthcare medical devices announced
today that Pifflers United Chronic and Invisible Illnesses Support
Community, www.facebook.com/PifflersUnited, is petitioning the
United Kingdom's NHS' National
Institute for Health & Care Excellence (NICE) for new
guidelines for effective Fibromyalgia pain management.
Fibromyalgia (FM) is a chronic condition of widespread pain and
profound fatigue. The pain tends to be felt as diffuse aching or
burning, often described as head to toe. Fibromyalgia
patients receive ad hoc treatment and NICE Guidelines for the
treatment of Fibromyalgia are needed to ensure sufferers are
treated appropriately and consistently.
The group members used ActiPatch Therapy and were
surveyed. Upon completion, the survey showed an average pain
reduction of 33% with 79% of them reporting a pain decrease.
When analyzed excluding those with no or very little pain
improvement, the therapeutic rate was 69% with a 47% reduction in
pain.
The Pifflers United petition calls on the UK Government to roll
out a cohesive plan for the treatment and management of
Fibromyalgia, including the following:
- Produce NICE Guidelines for the treatment of Fibromyalgia
- Arrange for Clinical Trials of the ActiPatch device, following
on from the 7-day trial results conducted by Fibromyalgia sufferers
in the online support community.
- Following on from successful clinical trials of ActiPatch, to
arrange for the ActiPatch device to be available on prepay
prescription for the treatment and management of Fibromyalgia
pain.
To view the e-petition and study results, please visit
www.facebook.com/PifflersUnited.
About BioElectronics Corporation
BioElectronics
Corporation is a leader in biophysics and the maker of an industry
leading family of disposable, drug-free, pain therapy devices:
ActiPatch® Therapy, over-the-counter treatment for back pain and
other musculoskeletal complaints; RecoveryRx® Devices for chronic
and post-operative wound care; Allay® Menstrual Pain Therapy; and
HealFast® Therapy for dogs, cats and horses. For more
information, please visit www.bielcorp.com.
BioElectronics Contact:
Paul
Knopick
940.262.3584
pknopick@eandecommunications.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/uk-fibromyalgia-sufferers-petition-the-national-health-service-to-integrate-and-pay-for-bioelectronics-actipatch-therapy-300001386.html
SOURCE BioElectronics Corporation